Work

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

Year: 2020

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-020-05931-9

Authors: Katya Losk, Rachel A. Freedman, Alison Laws, Olga Kantor, Elizabeth A. Mittendorf, Zhenying Tan-Wasielewski, Lorenzo Trippa, Nancy U. Lin, Eric P. Winer, Tari A. King

Institutions: Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Harvard University, Brigham and Women's Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Cancer Society, Susan G. Komen, National Institutes of Health, National Cancer Institute

Awards: G6407358767, G6543385616, Disparities in Breast Cancer Knowledge and Treatment Adherence, Individualizing surveillance mammography for older breast cancer survivors

OpenAlex ID: W3085295356

FWCI: 0.94

Cites: 27

Cited by: 14

Related to: 10